Trial
NCT01213329
Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwestern University
Collaborators
American Society of Transplant Surgeons
Condition
Kidney Transplant
Intervention
Alemtuzumab
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-10